|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | (2006.01) |
| C07K 16/36 | (2013.01) | ||
| G01N 33/50 | (2006.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/10 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3456744 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18186356.4 |
| Date of filing the European patent application | 2014-01-17 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361754607 P | 2013-01-20 | US |
| (72) |
SEXTON, Daniel, J. , US
FAUCETTE, Ryan , US
KENNISTON, Jon, A. , US
CONLEY, Greg , US
NIXON, Andrew , US
TENHOOR, Christopher , US
ADELMAN, Burt , US
CHYUNG, Yung , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
| (54) | EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS |
| EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS |